110

News

US firm snaps up Danish biomedical research firm for millions

Christian Wenande
May 7th, 2015


This article is more than 9 years old.

EpiTherapeutics sold Gilead Sciences for 444 million kroner

Kristian Helin, the CSO of EpiTherapeutics (photo: KU)

EpiTherapeutics, a biomedical research company developed by the University of Copenhagen (KU), has been sold to the US pharmaceutical company Gilead Sciences for 444 million kroner.

The company’s development programs are focused on epigenetics, which involves the regulatory system that controls human genes. The research could prove to be important for the treatment of a number of diseases, particularly cancer.

“We established EpiTherapeutics after we discovered a new protein family in my lab at KU,” said Kristian Helin, the CSO of EpiTherapeutics and a professor at KU.

“It’s given us a unique opportunity to build a bridge between the scientific foundation of cancer research and the development of new medicine. It’s generated new jobs and investment in Denmark.”

READ MORE: Danish researchers make important bowel cancer discovery

Useful for patients and funding
Until now, EpiTherapeutics has been owned by researchers at KU, while investors include Novo Seeds, Lundbeck Fonden Emerge, SEED Capital and Merck Serono Venture.

KU contended that the sale is an example of how biomedical research at the university can be translated into something useful for society – in terms of new medicine and regarding the funding of new research.

“It’s a great day for Danish biomedical research,” stated Martin Bonde, the CEO of EpiTherapeutics.

“With the sale, we have managed to translate and ennoble world-class research from KU into something which will benefit patients at the end of the day.”


Share

Most popular

Subscribe to our newsletter

Sign up to receive The Daily Post

















Latest Podcast

A survey carried out by Megafon for TV2 has found that 71 percent of parents have handed over children to daycare in spite of them being sick.

Moreover, 21 percent of those surveyed admitted to medicating their kids with paracetamol, such as Panodil, before sending them to school.

The FOLA parents’ organisation is shocked by the findings.

“I think it is absolutely crazy. It simply cannot be that a child goes to school sick and plays with lots of other children. Then we are faced with the fact that they will infect the whole institution,” said FOLA chair Signe Nielsen.

Pill pushers
At the Børnehuset daycare institution in Silkeborg a meeting was called where parents were implored not to bring their sick children to school.

At Børnehuset there are fears that parents prefer to pack their kids off with a pill without informing teachers.

“We occasionally have children who that they have had a pill for breakfast,” said headteacher Susanne Bødker. “You might think that it is a Panodil more than a vitamin pill, if it is a child who has just been sick, for example.”

Parents sick and tired
Parents, when confronted, often cite pressure at work as a reason for not being able to stay at home with their children.

Many declare that they simply cannot take another day off, as they are afraid of being fired.

Allan Randrup Thomsen, a professor of virology at KU, has heavily criticised the parents’ actions, describing the current situation as a “vicious circle”.

“It promotes the spread of viruses, and it adds momentum to a cycle where parents are pressured by high levels of sick-leave. If they then choose to send the children to daycare while they are still recovering, they keep the epidemic going in daycares, and this in turn puts a greater burden on the parents.”